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Introduction {#sec004}
============

Fluid challenge (FC) is the most frequently performed bedside haemodynamic intervention in perioperative care. This procedure is usually used to increase cardiac output (CO) so that oxygen delivery (DO~2~) matches oxygen consumption (VO~2~) \[[@pone.0205950.ref001], [@pone.0205950.ref002]\]. After FC, VO~2~ can either increase (if there is an oxygen debt) or remain unchanged \[[@pone.0205950.ref002]\]. In recent years, several studies have focused on parameters that are able to accurately track VO~2~/DO~2~ dependency \[[@pone.0205950.ref003]--[@pone.0205950.ref007]\]. Although the blood lactate concentration was initially described as a surrogate marker of VO~2~/DO~2~ dependency, an elevated lactate value may not necessarily reflect anaerobic metabolism \[[@pone.0205950.ref008]\]. Although ScvO~2~ might be indicative of DO~2~, its significance may be diminished during distributive shock with alteration of the oxygen extraction ratio (O~2~ER)---even after cardiac surgery \[[@pone.0205950.ref005], [@pone.0205950.ref009], [@pone.0205950.ref010]\]. It was recently suggested that the veno-arterial carbon dioxide tension gradient (pCO~2~ gap) and the pCO~2~ gap/C(a-v)O~2~ ratio are more sensitive indices of anaerobic metabolism and the VO~2~ increase upon FC \[[@pone.0205950.ref005], [@pone.0205950.ref011]--[@pone.0205950.ref014]\]. These parameters were developed and validated in ICU patients with sepsis, in whom they accurately predict an increase in VO~2~ with FC.

In clinical practice, the difficulty is to identify hemodynamic and/or oxygenation parameters that are clinically relevant to become endpoints for titration of interventions. Increasing DO~2~ is an accepted goal for optimization following cardiac surgery \[[@pone.0205950.ref015], [@pone.0205950.ref016]\] which is considered as a major surgery associated with high incidence of postoperative complications. Thus, predicting VO~2~ responsiveness can identify the patients for which DO~2~ increase is most beneficial \[[@pone.0205950.ref015], [@pone.0205950.ref016]\]. To date, these parameters have not been extensively studied in non-septic or post-operative patients. A few studies of postoperative cardiac surgery patients have shown that in contrary to the situation in patients with sepsis, pCO~2~ gap is poorly correlated with perfusion variables \[[@pone.0205950.ref017], [@pone.0205950.ref018]\].

The present study aims at investigating the ability of the pCO~2~ gap/C(a-v)O~2~ ratio and the C(a-v)CO~2~ content/C(a-v)O~2~ content ratio to predict a VO~2~ increase upon FC in postoperative cardiac surgery patients.

Material and methods {#sec005}
====================

Ethics {#sec006}
------

The study was approved by the independent ethics committee at Amiens University Hospital (Amiens, France). Because the protocol study is considered as observational and part of routine clinical practice, the French law did not require written consent. According to ethics committee, all patients received written information on the study. Oral consent was obtained from patient or subject's next of kin. The capacity to consent was checked by excluding confusion in awake patient who were not sedated. Confusion was assessed by clinical examination based on confusion assessment method for the intensive care unit. In case of confusion, the consent was obtained from subject's of kin. The consent was noted on study observation book. The present manuscript was drafted in compliance with the STROBE checklist for cohort studies \[[@pone.0205950.ref019]\].

Patients {#sec007}
--------

This observational study was performed in the cardiothoracic ICU at Amiens University Hospital (Amiens, France) between 2014 and 2017. Some of the patients were previously included in a study that evaluate association between end tidal carbon dioxide pressure and oxygen extraction \[[@pone.0205950.ref007]\]. The main inclusion criteria were as follows: age 18 or over, controlled positive ventilation, and a clinical decision to perform FC for volume expansion. The indications for FC were arterial hypotension (a systolic arterial pressure (SAP) below 90 mmHg and/or a mean arterial pressure (MAP) below 65 mmHg), a stroke volume (SV) variation of more than 10% during a passive leg raising manoeuver and/or clinical signs of hypoperfusion (skin mottling, and a capillary refill time of more than 3 sec). The non-inclusion criteria were permanent arrhythmia, heart conduction block, a pacemaker, poor echogenicity, aortic regurgitation, spontaneous ventilation, ongoing haemorrhage, and right heart dysfunction.

Haemodynamic parameters {#sec008}
-----------------------

Transthoracic echocardiography (with the CX50 ultrasound system and an S5-1 Sector Array Transducer, Philips Medical System, Suresnes, France) was performed by a physician who was blinded to the study outcomes. The left ventricular ejection fraction was measured using Simpson's biplane method with a four-chamber view. The aortic surface area (SAo, in cm^2^) was calculated as π×(diameter of the left ventricular outflow tract)^2^/4. The aortic velocity-time integral (VTIAo), was measured with pulsed Doppler at the LVOT on a five-chamber view. The SV (mL) was calculated as VTIAo×SAo. Cardiac output (CO) was calculated as SV×heart rate (HR) (ml min^-1^) and was expressed as an indexed CI, i.e. CO/body surface area (ml min^-1^ m^2^). Mean echocardiographic parameters were calculated from five measurements (regardless of the respiratory cycle) and analysed off lines.

Oxygenation parameters {#sec009}
----------------------

We recorded the ventilator settings (tidal volume, plateau pressure and end-expiratory pressure) at baseline. All blood gas parameters were measured with arterial and central venous catheters. Arterial and venous blood gas levels, the blood lactate level, the blood haemoglobin (Hb) concentration and oxyhaemoglobin saturation were measured using an automated analyser (ABL800 FLEX, Radiometer, Bronshoj, Denmark). Arterial oxygen content (CaO~2~) and venous oxygen content (CvO~2~) were calculated as follows: CaO~2~ = 1.34 x Hb x SaO~2~ + 0.003 x PaO~2~; CvO~2~ = 1.34 x Hb x ScvO~2~ + 0.003 x PvO~2~, where Hb is the haemoglobin concentration (g.dl^-1^), PaO~2~ is the arterial oxygen pressure (mmHg), SaO~2~ is the arterial oxygen saturation (%), PvO~2~ is the venous oxygen pressure (mmHg), ScvO~2~ is the central venous oxygen saturation (in%), and 0.003 is the solubility coefficient of oxygen \[[@pone.0205950.ref014]\]. pCO~2~ gap was calculated as follows: pCO~2~ gap = PcvCO~2~ --PaCO~2~ (mmHg). C(a-v)O~2~ was calculated as CaO~2~ minus CvO~2~ (ml) \[[@pone.0205950.ref014]\]. DO~2~ and VO~2~ were calculated from arterial and central venous blood gas measurements as follows: DO~2~ (ml min^-1^ m^-2^) = (CaO~2~ x 10 x CO)/body surface area; VO~2~ (ml min^-1^ m^-2^) = the arteriovenous difference in oxygen content (C(a-v)O~2~ x CO x 10)/body surface area. Arterial and venous CO~2~ contents (CaCO~2~, CvCO~2~) were calculated according to the Douglas formula \[[@pone.0205950.ref014], [@pone.0205950.ref020]\]. The C(a-v)CO~2~ content was calculated as CvCO~2~ minus CaCO~2~ (ml).

Protocol {#sec010}
--------

During the study period, the patients were mechanically ventilated in volume-controlled mode, with a tidal volume set to 7--9 ml kg^-1^ ideal body weight, and a positive end-expiratory pressure (PEEP) of 5--8 cmH~2~O. The patients were sedated with propofol, with a target Ramsay score \>5. The ventilator settings (oxygen inspired fraction, tidal volume, respiratory rate, and end positive pressure) were not modified during the study period.

The following clinical parameters were recorded: age, gender, weight, ventilation parameters, and primary diagnosis. After an equilibration period, HR, SAP, MAP, diastolic arterial pressure, central venous pressure (CVP), SV, CO, and arterial/venous blood gas levels were measured at baseline. In the present study, FC always consisted of a 10-minute infusion of 500 ml of Ringer\'s lactate solution. Immediately after FC, a second set of measurements was made.

Statistical analysis {#sec011}
--------------------

The variables\' distribution was assessed using a Shapiro-Wilk test. Data were expressed as the number, proportion (in percent), mean ± standard deviation (SD) or the median \[interquartile range (IQR)\], as appropriate. Patients were classified as fluid responders or non-responders as a function of the effect of FC on the SV. An FC response was defined as an increase of more than 15% in the SV after FC \[[@pone.0205950.ref021]\]. Patients were classified as VO~2~ responders or non-responders as a function of the effect of FC on VO~2~. A VO~2~ response was defined as an increase of more than 15% in the VO~2~ after FC \[[@pone.0205950.ref007]\]. The non-parametric Wilcoxon rank sum test, Student's paired t test, Student's t test, and the Mann-Whitney test were used to assess statistical significance, as appropriate. Linear correlations were tested using Pearson\'s or Spearman\'s rank method. A receiver-operating characteristic curve was used to establish the ability of ScvO~2~, pCO~2~ gap/C(a-v)O~2~ ratio or the C(a-v)CO~2~ content/C(a-v)O~2~ content ratio to predict an increase of more than 15% in VO~2~ \[[@pone.0205950.ref007], [@pone.0205950.ref014]\]. Assuming that 60% of patients would be fluid responders and that 20 to 30% of fluid responders would be VO~2~ responders, we calculated that a sample of 105 patients was sufficient to demonstrate that the pCO~2~ gap/C(a-v)O~2~ ratio predict an increase in VO~2~ upon FC with an area under the curve (AUC) greater than 0.80, a power of 80%, and an alpha risk of 0.05. Taking the exclusion criteria and incomplete data in account, the sample size was set to 115 participants. The threshold for statistical significance was set to *p*\<0.05. SPSS software (version 24, IBM, New York, NY, USA) was used for all statistical analyses.

Results {#sec012}
=======

Patients {#sec013}
--------

All patients had undergone cardiovascular surgery with cardiopulmonary bypass [Table 1](#pone.0205950.t001){ref-type="table"}, [Fig 1](#pone.0205950.g001){ref-type="fig"}. Of the 115 included patients, five were excluded ([Fig 1](#pone.0205950.g001){ref-type="fig"}), and so the final analysis covered 110 patients. Of these, 92 (84%) were classified as FC responders, and 43 (47%) were classified as VO~2~ responders.

![Flow chart diagram of the study.](pone.0205950.g001){#pone.0205950.g001}

10.1371/journal.pone.0205950.t001

###### Characteristics of the study participants on inclusion.

![](pone.0205950.t001){#pone.0205950.t001g}

  ------------------------------------------------------------------------------------
  Variables                                                      Overall population\
                                                                 (n = 110)
  -------------------------------------------------------------- ---------------------
  Age (mean (SD), years)                                         69 (11)

  Gender (F/M)                                                   32 /78

  Surgery, n (%)                                                 

      Valvular                                                   55 (50)

      CABG                                                       30 (27)

      Combined surgery                                           15 (14)

      Other                                                      6 (9)

  SAPS 2                                                         40 (13)

  Respiratory parameters                                         

  Tidal volume (ml kg^-1^ of predicted body weight, mean (SD),   7.8 (0.6)

  Total PEEP (cmH~2~O, mean (SD))                                6 (1)

  Number of patients treated with norepinephrine (n, %)          25 (25)

      Median dose (gamma Kg^-1^ min^-1^)                         0.7 (0.5 to 1.4)

  Number of patients treated with dobutamine (n, %)              4 (5)

      Median dose (gamma Kg^-1^ min^-1^)                         5 (5 to 7)

  LVEF (%, mean (SD))                                            49 (11)
  ------------------------------------------------------------------------------------

Values are expressed as the mean ± SD or the number (%). CABG: coronary artery bypass graft.

Effect of FC on haemodynamic and oxygenation parameters in the population as a whole {#sec014}
------------------------------------------------------------------------------------

FC was associated with increases in MAP, CVP, SV, CO, DO~2~, and VO~2~, and decreases in HR, and pCO~2~ gap [Table 2](#pone.0205950.t002){ref-type="table"}. At baseline, the arterial lactate concentration was not correlated with ScvO~2~ (r = -0.044, p = 0.650), pCO~2~ gap/C(a-v)O~2~ ratio (r = 0.052, p = 0.587), or C(a-v)CO~2~ content /C(a-v)O~2~ content ratio (r = 0.019, p = 0.841).

10.1371/journal.pone.0205950.t002

###### Comparison of haemodynamic parameters according to response of VO~2~.

![](pone.0205950.t002){#pone.0205950.t002g}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
   Hemodynamic variables                       VO~2~ responders\                                       VO~2~ non responders\                                   *p value*
                                               (n = 43)                                                (n = 49)                                                
  -------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ---------------
  Respiratory minute ventilation (l min^-1^)   **8.2 (1.3)**                                           **8 (1)**                                               ***0*.*290***

  Body temperature (°C)                        **36.3 (1.7)**                                          **36.6 (0.4)**                                          ***0*.*273***

  Capillary refill time (sec)                                                                                                                                  

  Pre-FC                                       **3.6 (1.5)**                                           **3.6 (1.3)**                                           ***0*.*908***

  Post-FC                                      **3.2 (1.2)** [^a^](#t002fn002){ref-type="table-fn"}    **2.9 (1.4)** [^a^](#t002fn002){ref-type="table-fn"}    ***0*.*289***

  Haemoglobin (g dl^-1^)                                                                                                                                       

  Pre-FC                                       **11.4 (1.6)**                                          **11.2 (1.4)**                                          ***0*.*518***

  Post-FC                                      **11.2 (1.7)** [^a^](#t002fn002){ref-type="table-fn"}   **10.8 (1.4)** [^a^](#t002fn002){ref-type="table-fn"}   ***0*.*210***

  HR (bpm)                                                                                                                                                     

  Pre-FC                                       **82 (22)**                                             **85 (19)**                                             ***0*.*574***

  Post-FC                                      **78 (21)** [^a^](#t002fn002){ref-type="table-fn"}      **81 (16)** [^a^](#t002fn002){ref-type="table-fn"}      ***0*.*404***

  MAP (mmHg)                                                                                                                                                   

  Pre-FC                                       **74 (14)**                                             **70 (12)**                                             ***0*.*140***

  Post-FC                                      **84 (16)** [^a^](#t002fn002){ref-type="table-fn"}      **82 (12)** [^a^](#t002fn002){ref-type="table-fn"}      ***0*.*472***

  SV (ml)                                                                                                                                                      

  Pre-FC                                       **44 (15)**                                             **42 (15)**                                             ***0*.*652***

  Post-FC                                      **60 (18)** [^a^](#t002fn002){ref-type="table-fn"}      **55 (21)** [^a^](#t002fn002){ref-type="table-fn"}      ***0*.*263***

  CI (ml min^-1^ m^-2^)                                                                                                                                        

  Pre-FC                                       **1.7 (0.6)**                                           **1.8 (0.7)**                                           ***0*.*524***

  Post-FC                                      **2.3 (0.7)** [^a^](#t002fn002){ref-type="table-fn"}    **2.2 (0.9)** [^a^](#t002fn002){ref-type="table-fn"}    ***0*.*921***

  DO~2~ (ml min^-1^ m^-2^)                                                                                                                                     

  Pre-FC                                       **269 (103)**                                           **274 (95)**                                            ***0*.*811***

  Post-FC                                      **339 (124)** [^a^](#t002fn002){ref-type="table-fn"}    **319 (119)** [^a^](#t002fn002){ref-type="table-fn"}    ***0*.*428***

  VO~2~ (ml min^-1^ m^-2^)                                                                                                                                     

  Pre-FC                                       **75 (34)**                                             **100 (39)**                                            ***0*.*002***

  Post-FC                                      **115 (37)** [^a^](#t002fn002){ref-type="table-fn"}     **93 (31)**                                             ***0*.*007***
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are expressed as the mean (SD) or the median \[interquartile range\]. **CI**, indexed cardiac output; ***DO***~***2***~, oxygen delivery; **FC**, fluid challenge; **HR**, heart rate; **MAP**, mean arterial pressure; **SV**, stroke volume; ***VO***~***2***~, oxygen consumption

^**a**^: *p*\<0.05 within groups (pre-/post-FC).

Differences between VO~2~ responders and VO~2~ non-responders among fluid responders {#sec015}
------------------------------------------------------------------------------------

Of the 92 FC responders, 43 (46%) were VO~2~ responders ([Fig 1](#pone.0205950.g001){ref-type="fig"}). All VO~2~ responders were FC responders [Table 2](#pone.0205950.t002){ref-type="table"}. FC increased MAP, SV, and CI in the two groups [Table 2](#pone.0205950.t002){ref-type="table"}.

At baseline, pCO~2~ gap and C(a-v)O~2~ were lower in VO~2~ responders than in VO~2~ non-responders, and ScvO~2~ was higher [Table 3](#pone.0205950.t003){ref-type="table"}. The arterial lactate concentration did not differ when comparing the two groups, and did not change upon FC. Furthermore, FC increased ScvO~2~ in VO~2~ non-responders and decreased ScvO~2~ in VO~2~ responders. FC decreased pvCO~2~ and pCO~2~ gap in VO~2~ non-responders only [Table 3](#pone.0205950.t003){ref-type="table"}. The pCO~2~ gap/C(a-v)O~2~ ratio and the C(a-v)CO~2~ content/C(a-v)O~2~ content ratio did not change upon FC.

10.1371/journal.pone.0205950.t003

###### Comparison of perfusion parameters according to response of VO~2~.

![](pone.0205950.t003){#pone.0205950.t003g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                                                           VO~2~ responders\                                        VO~2~ non responders\                                          *p value*
                                                                      (n = 43)                                                 (n = 49)                                                       
  ------------------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------------- ---------------
  **Arterial pH**                                                                                                                                                                             

  **Pre-FC**                                                          **7.35 (0.07)**                                          **7.38 (0.2)**                                                 ***0*.*447***

  **Post-FC**                                                         **7.38 (0.05)** [^a^](#t003fn002){ref-type="table-fn"}   **7.39 (0.2)**                                                 ***0*.*667***

  **Venous pH**                                                                                                                                                                               

  **Pre-FC**                                                          **7.32 (0.05)**                                          **7.33 (0.2)**                                                 ***0*.*751***

  **Post-FC**                                                         **7.32 (0.06)**                                          **7.33 (0.2)**                                                 ***0*.*728***

  **Oxygen arterial saturation (%)**                                                                                                                                                          

  **Pre-FC**                                                          **97.6 (1.2)**                                           **97.7 (1.7)**                                                 ***0*.*679***

  **Post-FC**                                                         **97.4 (1.7)**                                           **97.6 (1.4)**                                                 ***0*.*628***

  **ScvO**~**2**~ **(%)**                                                                                                                                                                     

  **Pre-FC**                                                          **67.7 (12)**                                            **60.8 (10)**                                                  ***0*.*003***

  **Post-FC**                                                         **62.8 (9)** [^a^](#t003fn002){ref-type="table-fn"}      **68.4 (10)** [^a^](#t003fn002){ref-type="table-fn"}           ***0*.*005***

  **PaCO**~**2**~ **(mmHg)**                                                                                                                                                                  

  **Pre-FC**                                                          **38.4 (5)**                                             **36.4 (5)**                                                   ***0*.*068***

  **Post-FC**                                                         **37.3 (4)**                                             **36.7 (5)**                                                   ***0*.*510***

  **PvCO**~**2**~ **(mmHg)**                                                                                                                                                                  

  **Pre-FC**                                                          **46.7 (6.1)**                                           **46.6 (5.4)**                                                 ***0*.*942***

  **Post-FC**                                                         **46.5 (5.4)**                                           **44.7 (5.3)** [^a^](#t003fn002){ref-type="table-fn"}          ***0*.*104***

  **pCO**~**2**~ **gap (mmHg)**                                                                                                                                                               

  **Pre-FC**                                                          **8.3 (3.7)**                                            **10 (3.3)**                                                   ***0*.*020***

  **Post-FC**                                                         **9.2 (3.8)**                                            **8 (3.6)** [^a^](#t003fn002){ref-type="table-fn"}             ***0*.*143***

  **CaO**~**2**~ **(ml)**                                                                                                                                                                     

  **Pre-FC**                                                          **15.4 (2.2)**                                           **15.1 (2)**                                                   ***0*.*555***

  **Post-FC**                                                         **15 (2.2)** [^a^](#t003fn002){ref-type="table-fn"}      **14.4 (1.9)** [^a^](#t003fn002){ref-type="table-fn"}          ***0*.*171***

  **CvO**~**2**~ **(ml)**                                                                                                                                                                     

  **Pre-FC**                                                          **10.8 (2.7)**                                           **9.5 (2.1)**                                                  ***0*.*009***

  **Post-FC**                                                         **9.7 (2.2)** [^a^](#t003fn002){ref-type="table-fn"}     **10.2 (2.2)** [^a^](#t003fn002){ref-type="table-fn"}          ***0*.*285***

  **C(a-v)O**~**2**~ **(ml)**                                                                                                                                                                 

  **Pre-FC**                                                          **4.5 (1.8)**                                            **5.6 (1.6)**                                                  ***0*.*003***

  **Post-FC**                                                         **5.3 (1.2)** [^a^](#t003fn002){ref-type="table-fn"}     **4.2 (1.9)** [^a^](#t003fn002){ref-type="table-fn"}           ***0*.*002***

  **CaCO**~**2**~ **(ml)**                                                                                                                                                                    

  **Pre-FC**                                                          **51.2 (7)**                                             **48.3 (7.9)**                                                 ***0*.*034***

  **Post-FC**                                                         **52.1 (5.9)**                                           **49.8 (5.1)** [^a^](#t003fn002){ref-type="table-fn"}          ***0*.*052***

  **CvCO**~**2**~ **(ml)**                                                                                                                                                                    

  **Pre-FC**                                                          **57.3 (5.8)**                                           **55.6 (5.4)**                                                 ***0*.*052***

  **Post-FC**                                                         **56.9 (6.3)**                                           **53.2 (5.9)** [^a^](#t003fn002){ref-type="table-fn"}          ***0*.*004***

  **C(a-v)CO**~**2**~ **content (ml)**                                                                                                                                                        

  **Pre-FC**                                                          **5.8 (2.9--7.4)**                                       **6.8 (4.5--7.4)**                                             ***0*.*239***

  **Post-FC**                                                         **5.3 (3.5--7.3)**                                       **2.9 (1.6--6.1)** [^a^](#t003fn002){ref-type="table-fn"}      ***0*.*023***

  **pCO**~**2**~ **gap/C(a-v)O**~**2**~ **(mmHg ml**^**-1**^**)**                                                                                                                             

  **Pre-FC**                                                          **1.93 (1.36--2.29)**                                    **1.89 (1.42--2.)**                                            ***0*.*710***

  **Post-FC**                                                         **1.82 (1.39--2.21)**                                    **1.86 (1.36--2.29)** [^a^](#t003fn002){ref-type="table-fn"}   ***0*.*863***

  **C(a-v)CO**~**2**~ **content /C(a-v)O**~**2**~ **content ratio**                                                                                                                           

  **Pre-FC**                                                          **0.98 (0.43--2.06)**                                    **1.1 (0.86--1.85)**                                           ***0*.*625***

  **Post-FC**                                                         **0.96 (0.59--1.39)**                                    **0.81 (0.46--1.15)** [^a^](#t003fn002){ref-type="table-fn"}   ***0*.*109***

  **Arterial lactates (mmol l**^**-1**^**)**                                                                                                                                                  

  **Pre-FC**                                                          **1.8 (0.9)**                                            **1.9 (0.7)**                                                  ***0*.*590***

  **Post-FC**                                                         **1.8 (0.9)**                                            **2 (0.8)**                                                    ***0*.*251***
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Values are expressed as the mean (SD) or the median \[interquartile range\]. **FC**, fluid challenge; ***VO***~***2***~, oxygen consumption

^**a**^: *p*\<0.05 within groups (pre-/post-FC).

The FC-induced changes in the C(a-v)CO~2~ content/C(a-v)O~2~ content ratio and the pCO~2~ gap/C(a-v)O~2~ ratio were associated (r = 0.499, p\<0.0001), but neither was correlated with changes in VO~2~ (r = -0.092, p = 0.337 and r = -0.05, p = 0.957) or arterial lactates (r = 0.129, p = 0.18 and r = -0.10, p = 0.916). The FC-induced changes in VO~2~ and ScvO~2~ were associated (r = 0.61, p = 0.0001).

Ability of overall perfusion parameters to predict an increase in VO~2~ {#sec016}
-----------------------------------------------------------------------

With an AUC \[95% confidence interval (CI)\] of 0.52 \[0.39‒0.64\] and 0.53 \[0.4--0.65\], respectively; p = 0.757 and 0.71, respectively, the C(a-v)CO~2~ content /C(a-v)O~2~ content ratio and the pCO~2~ gap/C(a-v)O~2~ ratio did not predict FC-associated changes in VO~2~. Baseline ScvO~2~ was poorly predictive of an increase of more than 15% in the VO~2~, with an AUC \[95%CI\] of 0.67 \[0.55‒0.78\] (p\<0.0001).

Discussion {#sec017}
==========

Our study produced several relevant results. The pCO~2~ gap/C(a-v)O~2~ ratio and the C(a-v)CO~2~ content /C(a-v)O~2~ content ratio did not predict increase in VO~2~ in postoperative cardiac surgery patients. ScvO~2~ was poorly predictive of an FC-associated increase in VO~2~. The arterial lactate level was not associated with VO~2~ changes. These results suggest that physician should take in account the population studied before analysing oxygen derivate parameters and predicting VO~2~ dependency.

The pCO~2~ gap/C(a-v)O~2~ ratio and the C(a-v)CO~2~ content/C(a-v)O~2~ content ratio are known to be associated with anaerobic metabolism, lactate clearance, and mortality in ICU patients with sepsis \[[@pone.0205950.ref011], [@pone.0205950.ref012], [@pone.0205950.ref014]\]. The present study is the first to have specifically focused on postoperative patients. Our present results did not suggest that the above-mentioned ratios are of value in non-septic patients. There are several possible explanations for our findings. Most of these are probably related to the difference between the various study populations (i.e. sepsis vs cardiac surgery), which may alter the significance of and relationships between systemic parameters related to oxygen and carbon dioxide \[[@pone.0205950.ref009], [@pone.0205950.ref022]\].

In the present study, the relationship between FC and changes in arterial and venous carbon dioxide content/tension differed to that observed in patients with sepsis \[[@pone.0205950.ref006], [@pone.0205950.ref012], [@pone.0205950.ref014]\]. Baseline pCO~2~ gap was higher after cardiac surgery in VO~2~ non-responders, and decreased only in VO~2~ non-responders. In the context of sepsis, pCO~2~ gap is higher in VO~2~ responder patients, and decreases only in VO~2~ responder patients. We did not demonstrate differences in FC-induced changes in O~2~-derived parameters, relative to those observed in patients with sepsis. C(a-v)O~2~ decreased in VO~2~ non-responders (due to an increase in CvO~2~) and increased in VO~2~ responders (due to a decrease in CvO~2~). The physiological relationships that allow the pCO~2~ gap/C(a-v)O~2~ ratio and the C(a-v)CO~2~ content/C(a-v)O~2~ content ratio to be used as indicators of anaerobic metabolism are probably altered by the inability of pCO~2~ gap to adequately reflect tissue CO~2~ production and elimination \[[@pone.0205950.ref017]\]. Our group has already studied pCO~2~ gap as a prognostic factor for the postoperative course in cardiac surgery \[[@pone.0205950.ref017]\]. Even though pCO~2~ gap was poorly correlated with tissue perfusion parameters, we did not demonstrate an association between pCO~2~ gap and outcomes.

The divergence between sepsis and post-operative situations might be due to several factors. The extent of microcirculation alterations caused by sepsis or surgery/cardiopulmonary bypass may differ \[[@pone.0205950.ref023], [@pone.0205950.ref024]\]. It has been demonstrated that sepsis is systematically associated with the disruption of microcirculatory regulation, i.e. a decrease in the functional capillary index, absent/intermittent capillary flow, increased heterogeneity in the perfusion index, arteriovenous shunting, and cellular hypoxia \[[@pone.0205950.ref025]\]. Cardiac surgery with cardiopulmonary bypass is associated with a wide range of microcirculatory alterations, including a decrease in microvascular perfusion, increased heterogeneity in the perfusion index and red blood cell velocity, and arteriovenous shunting \[[@pone.0205950.ref023], [@pone.0205950.ref026]\]. These changes are associated with alterations in the arteriovenous oxygen difference, systemic oxygen consumption, and CO~2~ and O~2~ diffusion \[[@pone.0205950.ref027]\]. Moreover, cardiac surgery microcirculatory alterations may be induced by (amongst other factors) cardiopulmonary bypass haemodilution and temperature changes during the operative period. Haemodilution was demonstrated to alter the relationship between CO~2~ pressures and CO~2~ contents, which do not alter pCO~2~ gap in the same way as haemorrhage \[[@pone.0205950.ref028]\]. It was also demonstrated that anaesthetic agents alter regional critical DO~2~ and microcirculation by changing the peripheral vascular resistance \[[@pone.0205950.ref029]\]. When considering the above-mentioned arguments and data as a whole, the pCO~2~ gap/C(a-v)O~2~ ratio and the C(a-v)CO~2~ content/C(a-v) O~2~ content ratio do not reflect complex, inconsistent alterations in regional VO~2~, DO~2~ and the latter's interrelationships after cardiac surgery.

Our results confirmed those report by Fischer et al., who demonstrated that only ScvO~2~ was associated with VO~2~ dependency in postoperative patients after maximization of the SV by FC \[[@pone.0205950.ref030]\]. Nevertheless, ScvO~2~ remains poorly predictive of VO~2~ changes \[[@pone.0205950.ref010]\]. Our results and those of Fischer et al. confirm previous demonstrations of ScvO~2~'s poor ability to track VO~2~ changes \[[@pone.0205950.ref010]\]. Likewise, arterial lactate was not associated with VO~2~ changes in Fischer et al.'s study and in the present study. Arterial lactate is known to be a complex variable that may be not always be associated with tissue hypoxia/hypoperfusion and anaerobic metabolism \[[@pone.0205950.ref008]\]. At present, no clinical parameter has demonstrated its superiority to predict VO~2~ dependency. Only goal directed hemodynamic optimisation protocols have demonstrated a decrease of post-operative complications due to a maximisation of DO~2~. Further research is needed to identify and describe new indicators of VO~2~ dependency in non-septic patients. In this way, ventriculo-arterial coupling and mitochondrial PO~2~ may be of interest \[[@pone.0205950.ref031], [@pone.0205950.ref032]\].

The present studies had several limitations. The fact that pCO~2~ gap was measured in central venous blood (rather than mixed venous blood) might have underestimated CO~2~ exchange from splanchnic territories. However, other studies have used central venous blood to calculate VO~2~- and CO~2~-derived parameters \[[@pone.0205950.ref014]\]. The observed changes in O~2~- and CO~2~-derived parameter were small and reproducible \[[@pone.0205950.ref033]\]. We assessed VO~2~ using the Fick method, which may not be reliable in ICU patients. Nevertheless, previous studies have used the Fick method to calculate VO~2~ \[[@pone.0205950.ref006], [@pone.0205950.ref014]\]. The latter results were similar to those previously demonstrated to be predictive of VO~2~ changes. Lastly, we performed a single-centre study; however, our results are in line with those reported in Fischer et al.'s study \[[@pone.0205950.ref028]\].

Conclusions {#sec018}
===========

Our present results did not demonstrate the ability of the pCO~2~ gap/C(a-v)O~2~ ratio and C(a-v)CO~2~ content/C(a-v)O~2~ content ratio to predict VO~2~ dependency in postoperative cardiac surgery patients. The present finding demonstrated that the population studied should be consider at bedside when assessing VO~2~ dependency with oxygen derivate parameters. The effect of cardiac surgery and/or cardiopulmonary bypass on the relationship between CO~2~ content and CO~2~ partial pressure may explain in part this finding.
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